Diagnostic Criteria for Identifying Individuals at High Risk of Progression From Mild or Moderate to Severe Alcohol Use Disorder.
- Authors
- Miller, Alex P; Kuo, Sally I-Chun; Johnson, Emma C; Tillman, Rebecca; Brislin, Sarah J; Dick, Danielle M; Kamarajan, Chella; Kinreich, Sivan; Kramer, John; McCutcheon, Vivia V; Plawecki, Martin H; Porjesz, Bernice; Schuckit, Marc A; Salvatore, Jessica E; Edenberg, Howard J; Bucholz, Kathleen K; Meyers, Jaquelyn L; Agrawal, Arpana; Collaborative Study on the Genetics of Alcoholism (COGA)
- Year
- 2023
- Journal
- JAMA network open
- PMID
- 37815828
- DOI
- 10.1001/jamanetworkopen.2023.37192
- PMCID
- PMC10565602
IMPORTANCE: Current Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5) diagnoses of substance use disorders rely on criterion count-based approaches, disregarding severity grading indexed by individual criteria. OBJECTIVE: To examine correlates of alcohol use disorder (AUD) across count-based severity groups (ie, mild, moderate, mild-to-moderate, severe), identify specific diagnostic criteria indicative of greater severity, and evaluate whether specific criteria within mild-to-moderate AUD differentiate across relevant correlates and manifest in greater hazards of severe AUD development. DESIGN, SETTING, AND PARTICIPANTS: This cohort study involved 2 cohorts from the family-based Collaborative Study on the Genetics of Alcoholism (COGA) with 7 sites across the United States: cross-sectional (assessed 1991-2005) and longitudinal (assessed 2004-2019). Statistical analyses were conducted from December 2022 to June 2023. MAIN OUTCOMES AND MEASURES: Sociodemographic, alcohol-related, psychiatric comorbidity, brain electroencephalography (EEG), and AUD polygenic score measures as correlates of DSM-5 AUD levels (ie, mild, moderate, severe) and criterion severity-defined mild-to-moderate AUD diagnostic groups (ie, low-risk vs high-risk mild-to-moderate). RESULTS: A total of 13β―110 individuals from the cross-sectional COGA cohort (mean [SD] age, 37.8 [14.2] years) and 2818 individuals from the longitudinal COGA cohort (mean baseline [SD] age, 16.1 [3.2] years) were included. Associations with alcohol-related, psychiatric, EEG, and AUD polygenic score measures reinforced the role of increasing criterion counts as indexing severity. Yet within mild-to-moderate AUD (2-5 criteria), the presence of specific high-risk criteria (eg, withdrawal) identified a group reporting heavier drinking and greater psychiatric comorbidity even after accounting for criterion count differences. In longitudinal analyses, prior mild-to-moderate AUD characterized by endorsement of at least 1 high-risk criterion was associated with more accelerated progression to severe AUD (adjusted hazard ratio [aHR], 11.62; 95% CI, 7.54-17.92) compared with prior mild-to-moderate AUD without endorsement of high-risk criteria (aHR, 5.64; 95% CI, 3.28-9.70), independent of criterion count. CONCLUSIONS AND RELEVANCE: In this cohort study of a combined 15β―928 individuals, findings suggested that simple count-based AUD diagnostic approaches to estimating severe AUD vulnerability, which ignore heterogeneity among criteria, may be improved by emphasizing specific high-risk criteria. Such emphasis may allow better focus on individuals at the greatest risk and improve understanding of the development of AUD.
Cross-Sectional Collaborative Study on the Genetics of Alcoholism (COGA) Cohort (N = 13 110) Endorsement Rates and Item Response Theory (IRT) Response Curves for 11 Lifetime Alcohol Use Disorder (AUD) CriteriaB, The probability of endorsement of each AUD criteria, P(ΞΈ) (y-axis), is plotted as a function of increasing severity of the underlying AUD latent trait, ΞΈ (x-axis). The horizontal dotted line represents a 50% probability of endorsing criteria; the vertical dotted line represents 2 SD above the mean of AUD latent severity. Criteria with difficulty parameters of 2 or above (ie, to the right of intersection of vertical and horizontal lines: Failure to fulfill, Physical/psychological, Craving, Withdrawal, Given up/reduced, and Time spent) were identified as high-risk diagnostic criteria. Hazardous use refers to recurrent alcohol use (β₯3 times) in situations in which it is physically hazardous; Larger/longer = drinking in larger amounts or over longer periods than intended; Tolerance = need for markedly increased amounts of alcohol to achieve intoxication or desired effect or a markedly diminished effect with continued use of the same amount of alcohol; Cut down = persistent desire or 3 or more unsuccessful efforts to stop, cut down, or control drinking; Social/interpersonal = continued alcohol use despite having persistent or recurrent (β₯3 times) social or interpersonal problems caused or exacerbated by the effects of alcohol; Failure to fulfill = recurrent use of alcohol resulting in a failure to fulfill major role obligations at work, school, or home; Physical/psychological = continued drinking despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to be caused or exacerbated by drinking; Craving = craving or a strong desire or urge to use alcohol; Given up/reduced = important social, occupational, or recreational activities given up or reduced because of drinking; Withdrawal = the characteristic withdrawal syndrome for alcohol or drinking (or using a closely related substance) to relieve or avoid withdrawal symptoms; Time spent = a great deal of time spent in activities necessary to obtain, use, or recover from the effects of drinking.
Longitudinal Collaborative Study on the Genetics of Alcoholism (COGA) Cohort (N = 2818) Survival Curves and 95% Confidence Intervals for Progression to Severe Alcohol Use Disorder (AUD)All survival curves include no prior mild-to-moderate AUD as comparison and are adjusted for sex, race and ethnicity, and mild-to-moderate AUD criterion count. A, Survival curves additionally adjusted for endorsement of prior mild-to-moderate AUD. B, Survival curves additionally adjusted for mild vs moderate AUD. C, Survival curves additionally adjusted for low-risk vs high-risk mild-to-moderate AUD. Dotted lines represent point estimates of median survival ages (not accounting for 95% CIs): A, prior mild-to-moderate AUD = 34 years; B, mild AUD = undefined, moderate AUD = 31 years; C, low-risk mild-to-moderate AUD = undefined, high-risk mild-to-moderate AUD = 32 years.
No entities extracted from this document yet.
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| Agrawal A, Brislin SJ, Bucholz KK, . The Collaborative Study on the Genetics of Alcoholism: overview. Genes Brain Behav. Published online September 22, 2023. doi:10.1111/gbb.12864PMC1055079037736010 | β | β | β |
| American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association; 1994. | β | β | β |
| American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013. | β | β | β |
| American Psychiatric Association. Re: Inviting input on use of a term like βpreaddictionβ for identifying and intervening in substance misuse and mild/early-stage substance use disorder [NOT-DA-23-019]. Published online April 27, 2023. Accessed August 10, 2023. https://www.psychiatry.org/getattachment/8044e50c-0a5d-4b6a-b12a-5bda60acfb23/APA-Letter-NIDA-NIAAA-RFI-Proposed-Preaddiction-Diagnosis-04272023.pdf | β | β | β |
| Bailey AJ, Ingram PF, Howe LK, Finn PR. Is lower severity alcohol use disorder qualitatively different than more severe manifestations? an evaluation of multivariate symptom clusters. Addiction. 2022;117(6):1598-1608. doi:10.1111/add.1578534935218PMC9081272 | β | β | β |
| Bates D, MΓ€chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1-48. doi:10.18637/jss.v067.i01 | β | β | β |
| Boness CL, Lane SP, Sher KJ. Not all alcohol use disorder criteria are equally severe: toward severity grading of individual criteria in college drinkers. Psychol Addict Behav. 2019;33(1):35-49. doi:10.1037/adb000044330676037PMC6494471 | β | β | β |
| Boness CL. Adopting the term βpreaddictionβ would be a serious mistake. STAT. Published May 25, 2023. Accessed August 10, 2023. https://www.statnews.com/2023/05/25/preaddiction-substance-use-disorder-addiction-label/ | β | β | β |
| Bucholz KK, Cadoret R, Cloninger CR, . A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol. 1994;55(2):149-158. doi:10.15288/jsa.1994.55.1498189735 | β | β | β |
| Cai N, Revez JA, Adams MJ, ; MDD Working Group of the Psychiatric Genomics Consortium. Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 2020;52(4):437-447. doi:10.1038/s41588-020-0594-532231276PMC7906795 | β | β | β |
| Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394(10200):781-792. doi:10.1016/S0140-6736(19)31775-131478502 | β | β | β |
| Chalmers RP. mirt: a multidimensional item response theory package for the R environment. J Stat Softw. 2012;48:1-29. doi:10.18637/jss.v048.i06 | β | β | β |
| Denz R, KlaaΓen-Mielke R, Timmesfeld N. A comparison of different methods to adjust survival curves for confounders. Stat Med. 2023;42(10):1461-1479. doi:10.1002/sim.968136748630 | β | β | β |
| Dick DM, Balcke E, McCutcheon V, ; COGA Collaborators. The Collaborative Study on the Genetics of Alcoholism: sample and clinical data. Genes Brain Behav. 2023;e12860:e12860. doi:10.1111/gbb.1286037581339PMC10550787 | β | β | β |
| Fan AZ, Chou SP, Zhang H, Jung J, Grant BF. Prevalence and correlates of past-year recovery from DSM-5 alcohol use disorder: results from National Epidemiologic Survey on Alcohol and Related Conditions-III. Alcohol Clin Exp Res. 2019;43(11):2406-2420. doi:10.1111/acer.1419231580502 | β | β | β |
| Gallagher K. Preaddiction: a helpful term or reactionary misstep in addiction treatment? Mad In America. Published June 14, 2023. Accessed August 10, 2023. https://www.madinamerica.com/2023/06/preaddiction-a-helpful-shift-or-reactionary-misstep-in-addiction-treatment/ | β | β | β |
| Gauld C, Baillet E, Micoulaud-Franchi JA, Kervran C, Serre F, Auriacombe M. The centrality of craving in network analysis of five substance use disorders. Drug Alcohol Depend. 2023;245:109828. doi:10.1016/j.drugalcdep.2023.10982836868091 | β | β | β |
| Ge T, Chen CY, Ni Y, Feng YA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10(1):1776. doi:10.1038/s41467-019-09718-530992449PMC6467998 | β | β | β |
| Grant BF, Goldstein RB, Saha TD, . Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015;72(8):757-766. doi:10.1001/jamapsychiatry.2015.058426039070PMC5240584 | β | β | β |
| Helle AC, Trull TJ, Watts AL, McDowell Y, Sher KJ. Psychiatric comorbidity as a function of severity: DSM-5 alcohol use disorder and HiTOP classification of mental disorders. Alcohol Clin Exp Res. 2020;44(3):632-644. doi:10.1111/acer.1428432125715PMC7117865 | β | β | β |
| Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. A validity study of the SSAGA: a comparison with the SCAN. Addiction. 1999;94(9):1361-1370. doi:10.1046/j.1360-0443.1999.94913618.x10615721 | β | β | β |
| Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-773. doi:10.1016/S2215-0366(16)00104-827475769PMC6135092 | β | β | β |
| Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018;320(8):815-824. doi:10.1001/jama.2018.1140630167705PMC7391072 | β | β | β |
| Kranzler HR, Zhou H, Kember RL, . Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. Nat Commun. 2019;10(1):1499. doi:10.1038/s41467-019-09480-830940813PMC6445072 | β | β | β |
| Kurki MI, Karjalainen J, Palta P, ; FinnGen. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508-518. doi:10.1038/s41586-022-05473-836653562PMC9849126 | β | β | β |
| Lane SP, Sher KJ. Limits of current approaches to diagnosis severity based on criterion counts: an example with DSM-5 alcohol use disorder. Clin Psychol Sci. 2015;3(6):819-835. doi:10.1177/216770261455302626783505PMC4714779 | β | β | β |
| Lane SP, Steinley D, Sher KJ. Meta-analysis of DSM alcohol use disorder criteria severities: structural consistency is only βskin deepβ. Psychol Med. 2016;46(8):1769-1784. doi:10.1017/S003329171600040427019218PMC4894493 | β | β | β |
| Lee MR, Boness CL, McDowell YE, VergΓ©s A, Steinley DL, Sher KJ. Desistance and severity of alcohol use disorder: a lifespan-developmental investigation. Clin Psychol Sci. 2018;6(1):90-105. doi:10.1177/216770261773685229335673PMC5766269 | β | β | β |
| Litten RZ, Ryan ML, Falk DE, Reilly M, Fertig JB, Koob GF. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res. 2015;39(4):579-584. doi:10.1111/acer.1266925833016 | β | β | β |
| Lynskey MT, Nelson EC, Neuman RJ, . Limitations of DSM-IV operationalizations of alcohol abuse and dependence in a sample of Australian twins. Twin Res Hum Genet. 2005;8(6):574-584. doi:10.1375/twin.8.6.57416354499 | β | β | β |
| Mallard TT, Savage JE, Johnson EC, . Item-level genome-wide association study of the Alcohol Use Disorders Identification Test in three population-based cohorts. Am J Psychiatry. 2022;179(1):58-70. doi:10.1176/appi.ajp.2020.2009139033985350PMC9272895 | β | β | β |
| Mannes ZL, Shmulewitz D, Livne O, Stohl M, Hasin DS. Correlates of mild, moderate, and severe alcohol use disorder among adults with problem substance use: validity implications for DSM-5. Alcohol Clin Exp Res. 2021;45(10):2118-2129. doi:10.1111/acer.1470134581461PMC8602758 | β | β | β |
| Martin CS, Steinley DL, VergΓ©s A, Sher KJ. The proposed 2/11 symptom algorithm for DSM-5 substance-use disorders is too lenient [letter]. Psychol Med. 2011;41(9):2008-2010. doi:10.1017/S003329171100071721557890PMC4245011 | β | β | β |
| McCutcheon VV, Agrawal A, Heath AC, . Functioning of alcohol use disorder criteria among men and women with arrests for driving under the influence of alcohol. Alcohol Clin Exp Res. 2011;35(11):1985-1993. doi:10.1111/j.1530-0277.2011.01550.x21631541PMC3166544 | β | β | β |
| McLellan AT, Koob GF, Volkow ND. Preaddictionβa missing concept for treating substance use disorders. JAMA Psychiatry. 2022;79(8):749-751. doi:10.1001/jamapsychiatry.2022.165235793096 | β | β | β |
| Mewton L, Slade T, McBride O, Grove R, Teesson M. An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data. Addiction. 2011;106(5):941-950. doi:10.1111/j.1360-0443.2010.03340.x21205055 | β | β | β |
| Meyers JL, Brislin SJ, Kamarajan C, ; COGA Collaborators. The Collaborative Study on the Genetics of Alcoholism: brain function. Genes Brain Behav. 2023;e12862:e12862. doi:10.1111/gbb.1286237587903PMC10550791 | β | β | β |
| Preuss UW, Watzke S, Wurst FM; WHO/ISBRA Study on State; Trait Markers of Alcohol Use and Dependence Investigators. Dimensionality and stages of severity of DSM-5 criteria in an international sample of alcohol-consuming individuals. Psychol Med. 2014;44(15):3303-3314. doi:10.1017/S003329171400088925065388 | β | β | β |
| R Foundation for Statistical Computing. The R project for statistical computing. Accessed May 15, 2023. https://www.r-project.org/ | β | β | β |
| Rehm J, Gmel GE Sr, Gmel G, . The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction. 2017;112(6):968-1001. doi:10.1111/add.1375728220587PMC5434904 | β | β | β |
| Rehm J, Shield KD. Global burden of alcohol use disorders and alcohol liver disease. Biomedicines. 2019;7(4):99. doi:10.3390/biomedicines704009931847084PMC6966598 | β | β | β |
| Ruan Y, Lin YF, Feng YA, ; Stanley Global Asia Initiatives. Improving polygenic prediction in ancestrally diverse populations. Nat Genet. 2022;54(5):573-580. doi:10.1038/s41588-022-01054-735513724PMC9117455 | β | β | β |
| Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 national and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73-e79. doi:10.1016/j.amepre.2015.05.03126477807 | β | β | β |
| Slade T, Mewton L, OβDean S, . DSM-5 and ICD-11 alcohol use disorder criteria in young adult regular drinkers: lifetime prevalence and age of onset. Drug Alcohol Depend. 2021;229(Pt B):109184. doi:10.1016/j.drugalcdep.2021.10918434813987 | β | β | β |
| Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health [HHS Publ No PEP22-07-005, NSDUH Ser H-57]. Accessed September 7, 2023. https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report | β | β | β |
| Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Springer; 2000. | β | β | β |
| Therneau TM. A package for survival analysis in R. R package version 3.5-3. February 12, 2023. Accessed May 15, 2023. https://cran.r-project.org/web/packages/survival/index.html | β | β | β |
| Thorp JG, Campos AI, Grotzinger AD, ; 23andMe Research Team. Symptom-level modelling unravels the shared genetic architecture of anxiety and depression. Nat Hum Behav. 2021;5(10):1432-1442. doi:10.1038/s41562-021-01094-933859377 | β | β | β |
| Vize CE, Lane SP. Reliability of differential item functioning in alcohol use disorder: bayesian meta-analysis of criteria discrimination estimates. Assessment. 2022;29(5):925-939. doi:10.1177/107319112098661333615848PMC9303006 | β | β | β |
| Walters RK, Polimanti R, Johnson EC, ; 23andMe Research Team. Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nat Neurosci. 2018;21(12):1656-1669. doi:10.1038/s41593-018-0275-130482948PMC6430207 | β | β | β |
| Watts AL, Boness CL, Loeffelman JE, Steinley D, Sher KJ. Does crude measurement contribute to observed unidimensionality of psychological constructs? a demonstration with DSM-5 alcohol use disorder. J Abnorm Psychol. 2021;130(5):512-524. doi:10.1037/abn000067834472887PMC8443156 | β | β | β |
| Watts AL, Watson D, Heath AC, Sher KJ. Alcohol use disorder criteria exhibit different comorbidity patterns. Addiction. 2023;118(8):1457-1468. doi:10.1111/add.1612136606740 | β | β | β |
| Zhou H, Sealock JM, Sanchez-Roige S, . Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. Nat Neurosci. 2020;23(7):809-818. doi:10.1038/s41593-020-0643-532451486PMC7485556 | β | β | β |
No papers in this knowledge base cite this source.
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| The Role of Glucagon-Like Peptide-1 Receptor Agonists in Prompting a Meaningful Improvement in Alcohol Use Disorder. | Meilinger A et al. | β | 2026 | β |
| Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. | Zimmermann S et al. | β | 2025 | β |
| Exploring Fit in a Mobile Health Intervention for Alcohol Use Disorder: Qualitative Study. | Jacobson N et al. | β | 2025 | β |
| Exploring how women with HIV develop hazardous drinking patterns: a qualitative assessment of drinking histories. | Parisi CE et al. | β | 2025 | β |
| Genetic risk for alcohol use disorder in relation to individual symptom criteria: Do polygenic indices provide unique information for understanding severity and heterogeneity? | Sarles YM et al. | β | 2025 | β |
| Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches. | Pich EM et al. | β | 2025 | β |
| Safety and Effectiveness of Naltrexone in the Management of Alcohol Use Disorder in Patients With Alcohol-associated Cirrhosis: First Clinical Observation From Indian Cohort. | Varshney M et al. | β | 2025 | β |
| Symptoms of problematic alcohol use differ in their genetic associations with comorbid internalizing, externalizing, and neurodevelopmental psychiatric disorders | Wang FL et al. | β | 2025 | β |
| A randomized trial testing digital medicine support models for mild-to-moderate alcohol use disorder. | Quanbeck A et al. | β | 2024 | β |
| Associations between alcohol use disorder polygenic score andΒ remission in participants from high-risk families and the Indiana Biobank. | Lai D et al. | β | 2024 | β |
| Associations between changes in deprivation and alcohol use disorder: a nationwide longitudinal study. | Kim DB et al. | β | 2024 | β |
| Does This Patient Have Alcohol Use Disorder?: The Rational Clinical Examination Systematic Review. | Wood E et al. | β | 2024 | β |
| Generalized genetic liability to substance use disorders. | Miller AP et al. | β | 2024 | β |
| Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. | Rush AJ et al. | β | 2024 | β |
| Understanding alcohol use and alcohol use disorders from a developmental psychopathology perspective: Research advances, challenges, and future directions. | Chassin L et al. | β | 2024 | β |